Non-toxicPseudomonas aeruginosaexotoxin A expressing the FMDV VP1 G-H loop for mucosal vaccination of swine against foot and mouth disease virus

• Published in: Vaccine 2007-04, Vol.25 (17), p.3328
• Main Authors: Challa, Sreerupa, Barrette, Roger, Rood, Debra, Zinckgraf, John, French, Richard, Silbart, Lawrence
• Format: Article
• Language: English
• Subjects: Animal diseases; Foot & mouth disease; Immune response; Low density lipoprotein receptors; Nickel; Peptides; Proteins; Toxins; Vaccines; Waterborne diseases; Whooping cough
• ISSN: 0264-410X; 1873-2518
• DOI: 10.1016/j.vaccine.2007.01.006

Synthetic peptides derived from the G-H loop of the foot and mouth disease virus (FMDV) capsid protein VP1 are relatively poor at recapitulating the native conformation present in the virus, and thus are often poor immunogens. We hypothesized that a candidate mucosal vaccine against FMDV could be developed using the non-toxicPseudomonas aeruginosaexotoxin A (ntPE) to deliver the G-H loop in its native conformation. An added benefit of this approach is the potential for ntPE to serve as an effective carrier/adjuvant molecule for delivery of the fusion protein across the epithelial barrier by virtue of its capacity to bind to CD91. A chimeric protein (ntPE-GH) was generated by inserting the coding sequence of the G-H loop into an expression plasmid encoding ntPE, in place of the native Ib loop. Recombinant ntPE-GH and wild-type ntPE were each expressed inEscherichia coli, purified over a nickel resin, then administered intranasally to the pigs, with or without the mucosal adjuvant cholera toxin (CT). Both the ntPE and ntPE-GH induced mucosal and systemic immune responses against ntPE; moreover, ntPE-GH administered without CT induced anti-GH loop serum IgG antibodies. In conclusion, these data demonstrate that ntPE can be used as a mucosal carrier/adjuvant to induce an immune response against the VP1 G-H loop of FMDV.